Ultragenyx: Leading the Way in Rare Disease Medicine and Workplace Excellence May 26, 2023 by Mathieu Maurice Introducing Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a leading biopharmaceutical powerhouse dedicated to revolutionizing healthcare for those affected by rare and ultrarare diseases. Today, we proudly unveil our highly anticipated second …
